UK markets closed

Aytu BioPharma, Inc. (AYTU)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1100+0.0500 (+1.63%)
As of 02:56PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
98,498
107,399
96,669
65,632
27,632
Cost of revenue
36,204
40,767
44,386
36,432
8,281
Gross profit
62,294
66,632
52,283
29,200
19,351
Operating expenses
Research development
2,449
4,095
12,662
5,623
1,722
Selling general and administrative
60,469
70,078
69,880
55,808
31,060
Total operating expenses
67,917
78,961
88,386
67,440
37,272
Operating income or loss
-5,623
-12,329
-36,103
-38,240
-17,921
Total other income/expenses net
-11,546
-4,722
-72,786
-19,790
4,300
Income before tax
-17,169
-17,051
-108,889
-58,030
-13,621
Income tax expense
828
0
-110
259
0
Income from continuing operations
-17,997
-17,051
-108,779
-58,289
-13,621
Net income
-17,997
-17,051
-108,779
-58,289
-13,621
Net income available to common shareholders
-17,997
-17,051
-108,779
-58,289
-13,621
Basic EPS
-6.31
-5.11
-74.01
-69.60
-60.00
Diluted EPS
-6.31
-5.11
-74.01
-69.60
-60.00
Basic average shares
4,081
3,340
1,470
837.333
225.96
Diluted average shares
4,081
3,340
1,470
837.333
225.96